Electronic cigarette (e-cigarette) flavor restriction policies are associated with reductions in e-cigarette use.

Oseltamivir treatment during influenza episodes is associated with a reduced risk for serious neuropsychiatric events among children and teens.

Palivizumab injection (Synagis), an RSV prevention therapy for children, is being discontinued and will no longer be available as of December 31, 2025.

Serious infections significantly increase the mortality risk among adults with chronic liver disease, including those without cirrhosis.

In patients with high-risk OSA, CPAP improves cardiovascular outcomes, while harm may be seen in those with low-risk OSA.

Patients with IA may benefit from HIIT, which was linked to improved cardiorespiratory fitness without worsening disease activity.

Notable Drug Approvals.

The FDA has approved the Genio system for the treatment of patients with moderate to severe obstructive sleep apnea.

There was an increased risk for long COVID among patients with poor asthma control including those with asthma attacks (OR, 1.47; 95% CI, 1.09-1.97) and emergency room (ER) visits for asthma (OR, 1.52 ...

HealthDay News — A Legionnaires’ disease outbreak in Central Harlem has now sickened 90 people and caused three deaths, New York City health officials said Tuesday. The update comes just a few days ...

Spencer C. Payne, M.D., from the University of Virginia in Charlottesville, and colleagues updated the guidelines published in 2015 to address quality improvement opportunities for managing adult ...

The FDA has granted accelerated approval to Hernexeos for the treatment of adults with unresectable or metastatic non-squamous NSCLC.